Document is current
Any future updates will be listed below
-
Authors
Yanagidaira, Mitsugu https://orcid.org/0000-0002-4694-6227
Nagata, Tetsuya https://orcid.org/0000-0003-4111-2693
Hasegawa, Juri https://orcid.org/0000-0001-7799-4216
Ishii, Takashi
Ebihara, Satoe
Nawa, Makiko
Yokota, Takanori
-
Funding
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (22H00440)
MEXT | Japan Society for the Promotion of Science (19H01016)
MEXT | Japan Society for the Promotion of Science (19H01016)
MEXT | Japan Society for the Promotion of Science (22H00440)
TMDU priority research areas grant
Japan Agency for Medical Research and Development (18am0301003h0005)
Japan Agency for Medical Research and Development (20am0401006h0002)
- License Information
-
More Information
Article History
Received: 19 June 2024
Accepted: 13 November 2025
First Online: 22 December 2025
Competing interests
: T.Y. collaborates with Takeda Pharmaceutical Co., Ltd. and serves as an academic advisor for Rena Therapeutics Inc. and Nissan Chemical Corporation. The other authors declare no conflicts of interest.
